| Medikun Familia | |
|
Ste 6c Kim's Bldg Middle Road Gualo Rai Village Saipan MP 96950 | |
| (670) 323-8742 | |
| Not Available |
| Full Name | Medikun Familia |
|---|---|
| Speciality | Clinic/Center |
| Location | Ste 6c Kim's Bldg Middle Road, Saipan, Northern Mariana Islands |
| Authorized Official Name and Position | Gia B Ramos (DIRECTOR) |
| Authorized Official Contact | 6716884421 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Medikun Familia Po Box 9663 Tamuning GU 96931-5663 Ph: (670) 323-8742 | Medikun Familia Ste 6c Kim's Bldg Middle Road Gualo Rai Village Saipan MP 96950 Ph: (670) 323-8742 |
| NPI Number | 1982958336 |
|---|---|
| Provider Enumeration Date | 11/07/2012 |
| Last Update Date | 11/07/2012 |
| Medicare PECOS PAC ID | 2163645342 |
|---|---|
| Medicare Enrollment ID | O20140625000176 |
News Archive
Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced the initiation of its Phase 2 clinical trial of CEM-102 in patients with prosthetic joint infections (PJIs).
Viking Systems, Inc. today announced that a prototype version of its Next Generation 3DHD Vision System will be demonstrated with Sony's prototype 3DHD Medical Display in Sony's booth at Hospital Build Asia 2010 which will run May 11 -13 in Singapore.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier™, a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking (an acronym for the French "Conformite Europeenne") certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes improvement achieved with the EndoBarrier Gastrointestinal Liner.
The study, conducted by researchers at the University of Pennsylvania and Vanderbilt University, challenges the American Psychiatric Association guidelines that antidepressant medications are the only effective treatment for moderately to severely depressed patients.
From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new therapeutic strategies and nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982958336 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | 20755-0001-1 (Northern Mariana Islands) | Primary |
| Provider Name | Kimberly Hutchison |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1689761710 PECOS PAC ID: 7113965583 Enrollment ID: I20140721001871 |
News Archive
Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced the initiation of its Phase 2 clinical trial of CEM-102 in patients with prosthetic joint infections (PJIs).
Viking Systems, Inc. today announced that a prototype version of its Next Generation 3DHD Vision System will be demonstrated with Sony's prototype 3DHD Medical Display in Sony's booth at Hospital Build Asia 2010 which will run May 11 -13 in Singapore.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier™, a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking (an acronym for the French "Conformite Europeenne") certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes improvement achieved with the EndoBarrier Gastrointestinal Liner.
The study, conducted by researchers at the University of Pennsylvania and Vanderbilt University, challenges the American Psychiatric Association guidelines that antidepressant medications are the only effective treatment for moderately to severely depressed patients.
From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new therapeutic strategies and nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.
› Verified 1 days ago
News Archive
Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced the initiation of its Phase 2 clinical trial of CEM-102 in patients with prosthetic joint infections (PJIs).
Viking Systems, Inc. today announced that a prototype version of its Next Generation 3DHD Vision System will be demonstrated with Sony's prototype 3DHD Medical Display in Sony's booth at Hospital Build Asia 2010 which will run May 11 -13 in Singapore.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier™, a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking (an acronym for the French "Conformite Europeenne") certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes improvement achieved with the EndoBarrier Gastrointestinal Liner.
The study, conducted by researchers at the University of Pennsylvania and Vanderbilt University, challenges the American Psychiatric Association guidelines that antidepressant medications are the only effective treatment for moderately to severely depressed patients.
From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new therapeutic strategies and nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.
› Verified 1 days ago
Kaiser Group Of Medical Clinics & Residential Facilities, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Nauru Loop St, Marianas Business Plaza, 4th Floor, Rm 402, Saipan, MP 96950 Phone: 670-234-8005 Fax: 670-234-8028 | |
Medical Associates Of The Pacific Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: Marina Heights Business Park, Suite 100, Saipan, MP 96950 Phone: 670-323-9000 Fax: 670-323-9010 | |
Kagman Community Health Center, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 856 Chalan Tun Thomas P. Sablan San Antonio, Saipan, MP 96950 Phone: 670-256-5242 Fax: 670-256-5244 | |
Marianas Dental Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Tsl Plaza 2nd Floor Beach Road, Saipan, MP 96950 Phone: 670-234-3810 Fax: 670-234-3820 | |
Commonwealth Medical Center Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: Micro Beach Road, Garapan, Saipan, MP 96950 Phone: 670-989-2587 | |
Mmc & Pacific Labs, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: Jkr Building Beach Road Garapan, Saipan, MP 96950 Phone: 670-285-1401 Fax: 670-234-3926 | |
Modern Solutions Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1 Dahon Drive, Unit# Wc-3, Saipan, MP 96950 Phone: 670-234-5302 Fax: 670-234-5303 |